Gate Bioscience expands Lilly drug discovery deal worth more than $870 million - Reuters
Gate Bioscience expands Lilly drug discovery deal worth more than $870 million Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQMS10YTFmSVN4T3hpaW9qQUYwNzZha20yWTlzMlg0MFRHUklNd0V2dnRzRzV1LTlnbVNINDZoR2wtaWlOYzJuUDhLNDVFQmI3R1JOSFg2ZmVXM1oxd3RsOHIybzJnUkRDLUlKM2YweGNYeThzZ2txV3M3QVhxeFZRakl6SHhOVjA5SV9SSVdscWNyeTctTXdGNmdYdTdSUjQ0czhTYjlWSDAwQlB3QUJKMHdXWEVVTUhRNmJocWphemZuSlliYTJlUGp3?oc=5" target="_blank">Gate Bioscience expands Lilly drug discovery deal worth more than $870 million</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Becton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMMicron enters $600 million settlement of Netlist patent dispute - Reuters
Micron enters $600 million settlement of Netlist patent dispute Reuters
October 6, 2026 at 01:58 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMSpaceX seeks $40 billion to buy Nvidia chips, FT reports - Reuters
SpaceX seeks $40 billion to buy Nvidia chips, FT reports Reuters
October 6, 2026 at 10:43 PM